Intermetatarsal Bursitis in Patients with Rheumatoid Arthritis
- Conditions
- Intermetatarsal BursitisRheumatoid Arthritis
- Interventions
- Diagnostic Test: Magnetic resonance imagingDiagnostic Test: UltrasoundDrug: Corticosteroid injectionOther: Clinical foot evaluationOther: Picture of the feet
- Registration Number
- NCT05698563
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The aim of the study is to investigate the incidence and clinical implications of intermetatarsal bursitis (IMB) in patients with rheumatoid arthritis (RA).
The hypothesis is that IMB is a cause of pain in patients with RA.
- Detailed Description
Within the recent years more research have focused on IMB in patients with rheumatologic disorders. There is emerging evidence that IMB is an inflammatory alteration in line with synovitis in patients with RA, and presence of IMB have been linked to the early stages of RA, especially due to the focus of the published literature.
The clinical implications of the presence of IMB for the patients are yet to be understood. Limited studies have linked the occurrence of IMB to foot impairment, but no studies have been conducted investigating the direct association between forefoot pain and the presence/absence of IMB.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 105
- Age > 18 years
- Forefoot pain and diagnosed with RA (patient group)
- Diagnosed with an axial arthritis (control group)
- Age <18 years
- Open wounds or ongoing infection in the forefoot at the time of examination
- Persons with a history of significant trauma in the forefoot, e.g. any fracture or previous surgeries in the forefoot
- Persons who have previously received intermetatarsal treatment (Morton's neuroma or IMB) in the same foot, e.g. injection within 6 months or operation at any time
- Exclusion from MRI scan only:
- Persons with contraindications to participate in MRI scan
- Persons with severely impaired renal function (GFR <30 ml/min)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control group Magnetic resonance imaging Patients with other rheumatic diseases and absence of forefoot pain. Patient group Ultrasound Patients with rheumatoid arthritis and forefoot pain. Patient group Clinical foot evaluation Patients with rheumatoid arthritis and forefoot pain. Patient group Magnetic resonance imaging Patients with rheumatoid arthritis and forefoot pain. Patient group Corticosteroid injection Patients with rheumatoid arthritis and forefoot pain. Control group Ultrasound Patients with other rheumatic diseases and absence of forefoot pain. Patient group Picture of the feet Patients with rheumatoid arthritis and forefoot pain. Control group Picture of the feet Patients with other rheumatic diseases and absence of forefoot pain.
- Primary Outcome Measures
Name Time Method Change in Visual Analogue Score (VAS) score At inclusion, 1 and 3 month(s) post treatment Pain score related to the foot pain
Incidence of intermetatarsal bursitis on MRI 8 weeks High intensity on T2 weighted images, low signal on T1. Thin peripheral enhancement on T1 contrast enhanced pictures.
Incidence of intermetatarsal bursitis on US 8 weeks Hypoechoic mass between metatarsal heads. Activity on power/color doppler.
Incidence of other pathology on MRI 8 weeks Other than intermetatarsal bursitis
Incidence of other pathology on US 8 weeks Other than intermetatarsal bursitis
- Secondary Outcome Measures
Name Time Method Incidence of opening toes 1 day Presence of opening toes/V-sign/spreading toes.
Trial Locations
- Locations (1)
Rigshospitalet Glostrup
🇩🇰Glostrup, Denmark